Allurion Gastric Balloon | Weight Loss | Allurion
The Allurion Balloon is a regulated health product that bears the CE marking in accordance with this regulation. The indications for use of the Allurion Gastric Balloon System are to promote weight loss in individuals living with excess weight or …
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in ...
5 days ago · NATICK, Mass., January 24, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a ...
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in ...
5 days ago · Allurion Technologies, Inc., a company dedicated to ending obesity, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the ...
Allurion stock soars 70% on weight-loss therapy update
6 days ago · Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript Allurion announces $2.5 million private placement; expects Q4 revenue of $5.6 million Seeking Alpha’s Quant Rating on Allurion ...
Allurion Technologies Inc. (ALUR) - Yahoo Finance
Find the latest Allurion Technologies Inc. (ALUR) stock quote, history, news and other vital information to help you with your stock trading and investing.
Allurion Technologies Inc. (ALUR) - Stock Analysis
6 days ago · Get a real-time Allurion Technologies Inc. (ALUR) stock price quote with breaking news, financials, statistics, charts and more.
Allurion to Become Publicly Listed
NATICK, Mass. – February 9, 2023 – Allurion Technologies, Inc. (“Allurion”), a company dedicated to ending obesity, and Compute Health Acquisition Corp, a special purpose acquisition company (“Compute Health”) (NYSE: CPUH), today announced that they have entered into a definitive business combination agreement that will result in ...
About - Allurion
With 100,000 Balloons distributed worldwide, Allurion is backed by clinical evidence and helps patients lose 10–15% of their body weight in just 16 weeks*. How does it work? The Procedureless Elipse Gastric Balloon Program: Multicenter Experience in …
Allurion Technologies Shares Are Up Today: What's Going On?
5 days ago · Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to conduct a clinical study evaluating the combination of its Allurion ...
Allurion - Allurion Announces Plans To Optimize Muscle Mass …
Jan 23, 2025 · Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the Allurion Program with GLP-1 agonists to improve muscle mass and overall body composition. Previous studies in patients undergoing GLP-1 therapy have demonstrated …